Literature DB >> 6178343

Characterization of antigenic sites of human prostatic acid phosphatase.

B K Choe, H S Lillehoj, M K Dong, S Gleason, M Barron, N R Rose.   

Abstract

Human prostatic acid phosphatase [PAP] is antigenically uniquely different from acid phosphatases of other tissue origins. Nevertheless, a small degree of antigenic cross-reactivity between PAP and other lysosomal acid phosphatase(s) [LAP] has been suspected. In order to resolve this question, we have adopted two approaches: one involving structural studies by peptide mapping, and the other involving topological mapping through the use of uniquely defined antibodies. Purified PAP was dissociated into subunits and was further cleaved by chemical and enzymological methods. The limited digestion of PAP by submaxillary protease yielded three fragments [Sp-1, 2, and 3]. One of the fragments, Sp-3 [Mr = 11,000-12,000], was shown to regain catalytic activity after interaction with anti-PAP antibodies. This along with other data suggested that the active site is localized in the Sp-3 fragment. These submaxillary protease fragments were also used in the antigenic studies. For the detailed antigenic mapping studies, we prepared 12 monoclonal anti-PAP antibodies. These monoclonal anti-PAP antibodies exhibited a remarkably specific binding to PAP, particularly to the Sp-1 fragment, without binding to other acid phosphatase preparations. We also prepared lysosomal acid phosphatase [LAP] and raised anti-LAP antibodies in rabbits. The anti-LAP antibodies were fractionated into subpopulations by the preparative isoelectric focusing method. Three anti-LAP antibody subpopulations [pI 5.2, 6.9, and 7.5] exhibited specific binding to LAP. However, two anti-LAP subpopulations [pI 5.3 and and 6.8] showed binding to the Sp-3 fragment, an active site fragment of PAP. Thus, the PAP molecule seems to consist of three domains, namely, Sp-1, Sp-3, and Sp-2. Sp-3, which is the active site domain, is an antigenically cross-reactive region. The Sp-1 domain represents an antigenically unique region of PAP, whereas none of the antibodies studied thus far bind to the Sp-2 fragment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178343     DOI: 10.1111/j.1749-6632.1982.tb40301.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Comparison of the antigenic peptides between human prostatic and lysosomal acid phosphatases.

Authors:  H S Lee; C L Lee; S S Li
Journal:  J Protein Chem       Date:  1991-04

2.  A single domain of human prostatic acid phosphatase shows antibody-mediated restoration of catalytic activity.

Authors:  B K Choe; M K Dong; D Walz; S Gleason; N R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

3.  Monoclonal antibodies to human prostatic acid phosphatase: probes for antigenic study.

Authors:  H S Lillehoj; B K Choe; N R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

Review 4.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18

5.  The potential function of steroid sulphatase activity in steroid production and steroidogenic acute regulatory protein expression.

Authors:  Teruo Sugawara; Seiichiro Fujimoto
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

6.  Immunologically reactive tryptic fragments of human prostatic acid phosphatase.

Authors:  C L Lee; S S Li; T M Chu
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.